1WILKINSON RW, ROSS EL, POULSOM R, et al. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors[J]. Proc Natl Acad Sci USA, 2001, 98(18): 10256. 被引量：1
2TAMURA M, NISHIZAKA S, MAEDA Y, et al. Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A 2-restricted and tumor-specific cytotoxic T lymphocytes[J]. Jpn J Cancer Res, 2001, 92(7): 762. 被引量：1
3PEDLEY RB, HILL SA, BOXER GM, et al. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate[J]. Cancer, Res, 2001, 61(12): 4716. 被引量：1
4DEL GOVERNATORE M, HAMBLIN MR, SHEA CR, et al. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1 A chlorin (e 6) immunoconjugate[J]. Cancer Res, 2000, 60(15): 4200. 被引量：1
5HJELM SA, RAGNHAMMAR P, FAGERBERG J, et al. Clinical effects of monoclonal antibody 17-1 A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma. Cancer Immunol Immunother[J]. 1999 Nov, 48(8): 463. 被引量：1
6CONRY RM, ALLEN KO, LEE S, et al. Human autoantibodies to carcinoembryonic antigen(CEA)induced by a vaccinia-CEA vaccine[J]. Clin Cancer Res, 2000, 6(1): 34. 被引量：1
7HODGE JW, MCLAUGHLIN JP, KANTOR JA, et al. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replication avian pox virus to enhance T-cell immuniry and antitumor responses[J]. Vaccine, 1997, 15(4): 759. 被引量：1
8MARSHALL JL, HAWKINS MJ, TSANG KY, et al. Phase I studu in cancer patients of a replication-deffective avipox recombinant vaccine that expresses human carcinoembryonic antigen[J]. J Clin Oncol, 1999, 17(2): 332. 被引量：1
9ROSENBERG SA, LOTZE MT, YANG JC, et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients[J]. Ann Surg, 1999, 210(4): 474. 被引量：1
10QI Y, MOYANA T, BRESALIER R, et al. Antibody-targeted lymphokine-activated killer cells inhibit liver micrometastases in severe combined immunodeficient mice[J]. Gastroenterology, 1995, 109(6): 1950. 被引量：1
4Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology[ J]. Eur J Pharmacol,2006,533 ( 1/3 ) :69-76. 被引量：1
5Entschladen F, Drell TL, Lang K,et al. Tumour cellmigration,invasion and metastasis: navigation by neurotransmitters [ J ]. Lancet Oncol,2004,5 (4) :254-258. 被引量：1
6Yip D, Strickland AH, Karapetis CS, et al. Immunomodulation therapy in colorectal carcinoma[ J ]. Cancer Treat Rev, 2000,26 ( 3 ) : 169-172. 被引量：1
7Baxevanis CN, Papamihail M. Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy [ J ]. Crit Rev Oncol Hematol, 1994,16 (3) : 157-179. 被引量：1
8Germain RN. MHC-dependent antigen processing and peptide presentation:providing ligands for T lymphocyte activation [ J ]. Cell, 1994,76(2) :287-299. 被引量：1
9Boussiotis VA, Treeman GJ, Gribben JG, et al. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation [ J ]. Proc Nat Acad Sci USA, 1993,90 ( 23 ) : 11059-11063. 被引量：1
10Bruyns C, Gerard C, Velu T. Cancer escape from immune surveillance:how can it be overcome by gene transfer[ J ]. Eur J Cancer, 1994,30(8) :1176-1181. 被引量：1
